1.876 - 1.900 of 69.162
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- DAX Call 20.600,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,32x
- Analysis
- Dow Jones 30 Call 56.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,96x
- Analysis
- Dow Jones 30 Call 48.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,31x
- Analysis
- Dow Jones 30 Call 54.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 7,77x
- Analysis
- Dow Jones 30 Call 51.500,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 12,95x
- Analysis
- Dow Jones 30 Put 32.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,09x
- Analysis
- Dow Jones 30 Call 50.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,79x
- Analysis
- DAX Call 31.800,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 4,54x
- Analysis
- DAX Call 28.800,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 4,47x
- Analysis
- DAX Call 27.400,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 4,33x
- Analysis
- DAX Put 15.400,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 7,39x
- Analysis
- Dow Jones 30 Call 52.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 7,29x
- Analysis
- NASDAQ-100 Call 24.500,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,54x
- Analysis
- NASDAQ-100 Call 25.600,00 21 Aug 2026
- Goldman Sachs
- 21.08.26
- 8,82x
- Analysis
- Dow Jones 30 Put 48.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,60x
- Analysis
- Dow Jones 30 Put 45.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 7,41x
- Analysis
- Dow Jones 30 Put 30.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 5,95x
- Analysis
- Dow Jones 30 Put 50.000,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,05x
- Analysis
- Procter & Gamble Put 80,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,09x
- Analysis
- Wells Fargo & Co Put 60,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,06x
- Analysis
- Regeneron Pharmaceuticals Put 800,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,81x
- Analysis
- Linde Call 550,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 5,08x
- Analysis
- SAP Call 120,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 2,92x
- Analysis
- Procter & Gamble Call 240,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 5,95x
- Analysis
- Regeneron Pharmaceuticals Put 600,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,66x
- Analysis